13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 10 managers

Reported value

$375.9M

Holders

10

+0 new · −1 exited

Holders’ est. mark

−$166.4M

Price effect on 8 books still in the name

Largest holder

$274.4M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC385.2K$274.4M−$130.5MCut−$159.5M
Marex Group plc70.3K$50.1M−$11.9MAdded$13M
DANSKE BANK A/S60.1K$42.8M−$20.4MCut−$29.7M
Swiss Life Asset Management Ltd9.18K$6.53M−$3.11MCut−$3.62M
Leonteq Securities AG1.83K$1.3M−$260.6KAdded$493K
Aventura Private Wealth, LLC610$434.5KHeld
Ramiah Investment Group484$344.8K−$158.3KCut−$146.2K
Prestige Wealth Management Group LLC101$71.9K−$27.8KCut−$14.3K
Clark Wealth Partners5$3.56KHeld
CHESAPEAKE ASSET MANAGEMENT LLC1$712−$339Cut−$339

Who left

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.